Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 12:39 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 1,943 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Context 2 Clear all

Conditions: Anxiety
Interventions: Dream Yoga Inspired Intervention, Sleep Health Enhancement program; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 2
States / cities: Evanston, Illinois • Charlottesville, Virginia

Conditions: Pulmonary Disease, Chronic Obstructive, Lung Diseases, Obstructive
Interventions: Lifestyle Activity Program, Exercise Program; Behavioral
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: Not listed
Enrollment: 318 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2007
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Traumatic Brain Injury
Interventions: BETTER (Brain Injury, Education, Training, and Therapy to Enhance Recovery), Usual Care; Behavioral · Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Stroke, Hemiparesis, Upper Extremity Impairments, Stroke Rehabilitation
Interventions: Tele-CPASS, In-person CPASS therapy; Behavioral
Lead sponsor: University of Texas, El Paso; Other
Eligibility: 21 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 3
States / cities: El Paso, Texas

Conditions: Substance Use (Drugs, Alcohol), Health Risk Behaviors, Youth, Adolescent Behavior
Interventions: iDECIDE; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: Not listed
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Acute Myeloid Leukemia
Interventions: CIML NK Cell Infusion, CD3+ T Cell Product Infusion, Leukapheresis; Drug · Procedure
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Type 2 Diabetes, Glycemic Control, Psychological Distress
Interventions: LUNA Care Coordination, LUNA Behavioral Health, Health Education Videos, Virtual Integrated Visits; Behavioral
Lead sponsor: San Diego State University; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chula Vista, California

Conditions: Nurse's Role, Stigma, Social, Implicit Bias
Interventions: ArtSpective; Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 99 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 2
States / cities: Saint Cloud, Minnesota • Toledo, Ohio

Conditions: Metastatic Uveal Melanoma, Uveal Melanoma, Metastatic, Uveal Melanoma, Recurrent, Eye Cancer, Intraocular Melanoma, Eye Cancer
Interventions: NBM-BMX Capsule are proprietary products developed by Novelwise Pharmaceutical Corporation (Novelwise) for treatment of patients suffering from cancers.; Drug
Lead sponsor: Novelwise Pharmaceutical Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 3
States / cities: Scottsdale, Arizona • Denver, Colorado • Nashville, Tennessee

Conditions: Fistula Stenosis
Interventions: Paclitaxel, Standard Therapy; Drug · Procedure
Lead sponsor: Englewood Hospital and Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Englewood, New Jersey

Conditions: COVID-19
Interventions: Covid-19 Antibody Test, Short Clip videos; Diagnostic Test · Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 327 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Greensboro, North Carolina

Conditions: Extensive-stage Small-cell Lung Cancer, Small-cell Lung Cancer
Interventions: BNT327 Dose Level 1 (DL1), BNT327 Dose Level 2 (DL2), Etoposide, Carboplatin, Paclitaxel, Topotecan; Drug
Lead sponsor: BioNTech SE; Industry
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 18
States / cities: Anchorage, Alaska • Los Angeles, California • Clermont, Florida + 15 more

Conditions: Blood Pressure, Sleep Health, Diet, Healthy, Physical Activity, Weight Loss
Interventions: Multidimensional Sleep Health Sessions, Healthy Diet Sessions, Physical Activity Sessions; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 20 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: New York, New York

Conditions: Bronchial Asthma, Status Asthmaticus
Interventions: Standard of Care therapies, NiPPV Therapy, Routine Respiratory Care; Procedure · Device
Lead sponsor: Arkansas Children's Hospital Research Institute; Other
Eligibility: 2 Years to 17 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: HIV
Interventions: Emtricitabine and tenofovir disoproxil fumarate; Drug
Lead sponsor: Philadelphia Fight; Other
Eligibility: 18 Years to 30 Years · Male only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Type 2 Diabetes, Obesity
Interventions: Almased Meal Replacement Powder, Group-Based Lifestyle Intervention; Dietary Supplement · Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 21 Years and older
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Mental Health, Work Related Stress
Interventions: Coaching and Advancement for Peer Providers (CAPP); Behavioral
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 18 Years and older
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cardiovascular Disease Other, Physical Activity
Interventions: Physical Activity Lifestyle Intervention, Physical Activity Monitoring; Behavioral
Lead sponsor: Jamie Jackson; Other
Eligibility: 15 Years to 18 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Community Reinforcement And Family Training, Family Health, Substance-Related Disorders
Interventions: Community Reinforcement And Family Training, We The Village Peer Community Forum; Behavioral
Lead sponsor: We The Village, Inc.; Other
Eligibility: 19 Years and older
Enrollment: 212 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Metastatic HER2+ Advanced Breast Cancer
Interventions: Tucatinib, Trastuzumab, Capecitabine; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Antisocial Behavior
Interventions: Attention to Context (ATC) training, Affective Cognitive Control (ACC) training; Behavioral
Lead sponsor: The Mind Research Network; Other
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 288 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Stroke, Walking, Difficulty, Cardiovascular Injury
Interventions: Gait Training, Leg Cycling Exercise; Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Cerebral Palsy
Interventions: Let's Move Motor Intervention; Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 3 Months to 8 Months
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Diabetes Type 2, Diabetes Mellitus, Obesity
Interventions: Cryoablation of the Vagus Nerve, Lifestyle Intervention; Device · Behavioral
Lead sponsor: Emory University; Other
Eligibility: 22 Years to 65 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 5
States / cities: Atlanta, Georgia • Johns Creek, Georgia

Search by objective public record fields.

Feasibility of a Mental-Health Intervention Based on Contemplative Sleep Practices

Comparison of Two Programs to Encourage Physical Activity in Individuals With Chronic Obstructive Pulmonary Disease

BETTER (Brain Injury Education, Training, and Therapy to Enhance Recovery)

Efficacy of Tele-CPASS Compared to In-person CPASS Therapy for Upper Extremity Motor Recovery

Pilot of a Drug Education Curriculum for Middle and High School Students

Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant

Latinos Understanding the Need for Adherence in Diabetes Using E-Health

Testing an Arts-based Program to Reduce Nurse Stigma Towards Perinatal Substance Use

Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma

Paclitaxel for the Treatment of Upper-Extremity Arteriovenous Access Fistula Stenosis

RADx-UP CDCC Rapid Research Pilot Program "Culturally-relevant Community Connections (C3) to Increase COVID-19 Testing

Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy

The Sleep2BWell Trial

NiPPV in the Treatment of Acute Asthma Exacerbations

PrEP With TDF/FTC to Prevent HIV-1 Acquisition in Young MSM and Transgender Women of Color

Almased Multi-Center Diabetes Intervention Trial

Testing the Effectiveness of Mainstream Management Tools to Increase Organizational Commitment and Job Satisfaction and Decrease Turnover Among Peer Providers

Congenital Heart Disease Physical Activity Lifestyle Study

Scalable Digital Delivery of Evidence-based Training for Family to Maximize Treatment Admission Rates of Opioid Use Disorder in Loved Ones

Real World-clinical Outcomes of Tucatinib, Trastuzumab, and Capecitabine Following Trastuzumab Deruxtecan (T-DXd) for the Treatment of HER2-positive Metastatic Breast Cancer.

Matching Treatments to Cognitive Deficits in Offenders With Substance Use Disorders

To Develop a Walking Exercise Program for Non-ambulatory Stroke Survivors

Motor Training for Infants With Cerebral Palsy

Cryovagotomy Diabetes Trial